抗瓜氨酸化蛋白抗体阳性类风湿关节炎早期风险因素识别:一项前瞻性队列研究
本研究纳入267例抗CCP2阳性且无关节炎的肌肉骨骼症状患者,随访至少3年,101例(38%)在中位14个月后进展为关节炎。Cox回归模型识别出至少一种ACPA反应性、超声检测的腱鞘炎、IL-6水平及IL-15Rα水平为关节炎进展的独立预测因素,模型Harrell's C为0.76。作者提出以这些因素为特征的高RA风险阶段,并建议进一步研究其生物学效应和临床价值。
要点
- 抗CCP2阳性伴肌肉骨骼症状但无关节炎者中,38%在中位14个月内进展为关节炎。
- 至少一种ACPA反应性(HR 8.0)、超声腱鞘炎(HR 3.4)、IL-6(HR 1.5)及IL-15Rα(HR 0.6)为独立预测因素。
- 预测模型Harrell's C为0.76,AUC为0.82,交叉验证AUC为0.70。
核心结论
- 作者提出以ACPA反应性、腱鞘炎、IL-6和IL-15Rα为特征的高RA风险阶段,并建议进一步研究这些因素的生物学效应和临床价值,以识别关节炎进展低风险和高风险个体。
研究设计与样本
- 前瞻性队列研究,纳入267例抗CCP2阳性伴肌肉骨骼症状且临床和超声检查无关节炎的个体,随访至少3年或至临床关节炎诊断。
- 检测基线血样中9种ACPA反应性、92种炎症相关蛋白及HLA共享表位等位基因,采用Cox回归识别独立预测因素。
主要发现
- 中位随访49个月(IQR 22-60),101例(38%)在中位14个月(IQR 6-27)后发生关节炎。
- 至少一种ACPA反应性(HR 8.0;95%CI 2.9,22)、超声检测的腱鞘炎(HR 3.4;95%CI 2.0,6.0)、IL-6水平(HR 1.5;95%CI 1.2,1.8)及IL-15Rα水平(HR 0.6;95%CI 0.4,0.9)为关节炎进展的显著独立预测因素。
- 预测模型Harrell's C为0.76(s.e. 0.02),AUC为0.82(95%CI 0.76,0.89),交叉验证AUC为0.70(95%CI 0.56,0.85)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者建议这些因素需要进一步研究其生物学效应和临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Individuals positive for anti-cyclic-peptide-antibodies (anti-CCP) and musculoskeletal complaints (MSK-C) are at risk for developing rheumatoid arthritis (RA). In this study we aimed to investigate factors involved in arthritis progression. METHODS: Anti-CCP2-positive individuals with MSK-C referred to a rheumatologist were recruited. Individuals lacked arthritis at clinical and ultrasound examination and were followed for ≥3 years or until clinical arthritis diagnosis. Blood samples from inclusion were analysed for nine ACPA reactivities (citrullinated α-1-enolase, fibrinogen, filaggrin, histone, vimentin and tenascin peptides); 92 inflammation-associated proteins; and HLA-shared epitope alleles. Cox regression was applied to the data to identify independent predictors in a model. RESULTS: Two hundred and sixty-seven individuals were included with median follow-up of 49 months (interquartile range [IQR]: 22-60); 101 (38%) developed arthritis after a median of 14 months (IQR: 6-27). The analysis identified that presence of at least one ACPA reactivity (hazard ratio [HR] 8.0; 95% CI: 2.9, 22), ultrasound-detected tenosynovitis (HR 3.4; 95% CI: 2.0, 6.0), IL-6 levels (HR 1.5; 95% CI: 1.2, 1.8) and IL-15 receptor α (IL-15Rα) levels (HR 0.6; 95% CI: 0.4, 0.9) are significant independent predictors for arthritis progression in a prediction model (Harrell's C 0.76 [s.e. 0.02], AUC 0.82 [95% CI: 0.76, 0.89], cross-validated AUC 0.70 [95% CI: 0.56, 0.85]). CONCLUSION: We propose a high RA risk phase characterized by presence of ACPA reactivity, tenosynovitis, IL-6 and IL-15Rα and suggest that these factors need to be further investigated for their biological effects and clinical values, to identify individuals at particular low risk and high risk for arthritis progression.
引用
- Cîrciumaru A, Kisten Y, Hansson M, et al. Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis-a prospective cohort study. Rheumatology (Oxford). 2024. PMID: 38457608. doi:10.1093/rheumatology/keae146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。